Optimal Once-Daily Busulfan Administration in Pediatric Patients: A Simulation-Based Investigation of Intravenous Infusion Times

Optimal Once-Daily Busulfan Administration in Pediatric Patients: A Simulation-Based Investigation of Intravenous Infusion Times

Yun Kim,1 Sungha Moon,2 Su-Jin Rhee2 1College of Pharmacy, Daegu Catholic University, Gyeongsan, 38430, Republic of Korea; 2College of Pharmacy, Wonkwang University, Iksan, 54538, Republic of KoreaCorrespondence: Su-Jin Rhee, College of Pharmacy, Wonkwang University, Iksan, 54538, Republic of Korea,...

Full description

Bibliographic Details
Main Authors:	Kim Y, Moon S, Rhee SJ
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-03-01
Series:	Drug Design, Development and Therapy
Subjects:	busulfan pediatrics population pharmacokinetics once-daily dosing regimen infusion times
Online Access:	https://www.dovepress.com/optimal-once-daily-busulfan-administration-in-pediatric-patients-a-sim-peer-reviewed-fulltext-article-DDDT

Similar Items

Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience
by: Katharina M. Schreib, et al.
Published: (2023-12-01)

Efficacy and toxicity of once versus twice daily regimens of amikacin in febrile neutropenic pediatric cancer patients
by: Reda Abd-Elfattah, et al.
Published: (2017-03-01)

The effect on intraocular pressure of Latanoprost with once every other day dosing in glaucoma patients
by: Rana Sorkhabi, et al.
Published: (2013-04-01)

Assessment of a Model-Informed Precision Dosing Platform Use in Routine Clinical Care for Personalized Busulfan Therapy in the Pediatric Hematopoietic Cell Transplantation (HCT) Population
by: Praveen Shukla, et al.
Published: (2020-07-01)

Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation
by: Adrin Dadkhah, et al.
Published: (2022-05-01)

Busulfan/Cyclophosphamide Compared with Melphalan as a Conditioning Regimen for Autologous Transplantation of Multiple Myeloma: A Long-Term Assessment
by: Shiyuan Zhou, et al.
Published: (2023-09-01)

Efficacy in asthma of once-daily treatment with fluticasone furoate: a randomized, placebo-controlled trial
by: Jacques Loretta, et al.
Published: (2011-10-01)

Effect of <i>GSTA1</i> Variants on Busulfan-Based Conditioning Regimen Prior to Allogenic Hematopoietic Stem-Cell Transplantation in Pediatric Asians
by: Ai-Hoc Nguyen, et al.
Published: (2022-02-01)

The Correlation Between Busulfan Exposure and Clinical Outcomes in Chinese Pediatric Patients: A Population Pharmacokinetic Study
by: Xiaohuan Du, et al.
Published: (2022-06-01)

Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
by: Sylvain Goutelle, et al.
Published: (2022-10-01)

Lower Exposure to Busulfan Allows for Stable Engraftment of Donor Hematopoietic Stem Cells in Children with Mucopolysaccharidosis Type I: A Case Report of Four Patients
by: Praveen Shukla, et al.
Published: (2020-08-01)

Effects of intravenous multiple busulfan injection on suppression of endogenous spermatogenesis in recipient stallion testes
by: Heejun Jung, et al.
Published: (2021-09-01)

Comparative efficacy and safety profile of once-weekly Semaglutide versus once-daily Sitagliptin as an add-on to metformin in patients with type 2 diabetes: a systematic review and meta-analysis
by: Tirath Patel, et al.
Published: (2023-12-01)

Once daily nebulized beclomethasone is effective in maintaining pulmonary function and improving symptoms in asthmatic children
by: S. La Grutta, et al.
Published: (2016-02-01)

Estimation of genetic parameters and individual and maternal breed, heterosis, and recombination loss effects for production and fertility traits of spring-calved cows milked once daily or twice daily in New Zealand
by: J.M.D.R. Jayawardana, et al.
Published: (2023-01-01)

Physician experience with once-weekly somatrogon versus once-daily rhGH regimen in pediatric patients with growth hormone deficiency: a cross-sectional survey of physicians from the global phase 3 study
by: Roy Gomez, et al.
Published: (2023-10-01)

Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
by: Woodcock Ashley, et al.
Published: (2011-12-01)

Impact of <i>GSTA1</i> Polymorphisms on Busulfan Oral Clearance in Adult Patients Undergoing Hematopoietic Stem Cell Transplantation
by: Veronique Michaud, et al.
Published: (2019-09-01)

Heritabilities and genetic and phenotypic correlations for milk production and fertility traits of spring-calved once-daily or twice-daily milking cows in New Zealand
by: J.M.D.R. Jayawardana, et al.
Published: (2023-03-01)

Real-World Administration of Once-Daily MeltDose<sup>®</sup> Prolonged-Release Tacrolimus (LCPT) Allows for Dose Reduction of Tacrolimus and Stabilizes Graft Function Following Liver Transplantation
by: Katharina Willuweit, et al.
Published: (2020-12-01)

Latamoxef dosing regimen adjustments and pharmaceutical care in pediatrics
by: Ailin Zhang, et al.
Published: (2024-02-01)

Continuous-Infusion Vancomycin in Neonates: Assessment of a Dosing Regimen and Therapeutic Proposal
by: Manon Tauzin, et al.
Published: (2019-05-01)

Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus
by: Gantar K, et al.
Published: (2020-09-01)

Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma: A study of the Korean Multiple Myeloma Working Party (KMMWP-1801 study)
by: Ga-Young Song, et al.
Published: (2022-08-01)

Evaluation of Reversed Administration Order of Busulfan (BU) and Cyclophosphamide (CY) as Conditioning on Liver Toxicity in Allogenic Hematopoietic Stem Cell Transplantation (ALL-HSCT)
by: Mani Ramzi, et al.
Published: (2020-07-01)

Recuperación del epitelio germinal masculino de ratones tratados con dosis única de Busulfán
by: Luis Guzmán, et al.
Published: (2013-05-01)

Revefenacin: A Once-Daily, Long-Acting Bronchodilator For Nebulized Treatment Of COPD
by: Donohue JF, et al.
Published: (2019-12-01)

Intratesticular versus intraperitoneal injection of Busulfan for the induction of azoospermia in a rat model
by: Halimeh Mobarak, et al.
Published: (2022-07-01)

Can First-Dose Therapeutic Drug Monitoring Predict the Steady State Area Under the Blood Concentration-Time Curve of Busulfan in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation?
by: Abdullah Alsultan, et al.
Published: (2022-04-01)

Mesenchymal Stem Cells for Busulfan–Induced Azoospermia: An Experimental Study
by: Fawzy Mahmoud Ali Abougalala, et al.
Published: (2022-04-01)

Stereological study of the effect of ginger's alcoholic extract on the testis in busulfan-induced infertility in rats
by: Hossein Bordbar, et al.
Published: (2013-06-01)

Dose-dependent effects of busulfan on dog testes in preparation for spermatogonial stem cell transplantation
by: Tai-Young Hur, et al.
Published: (2017-12-01)

External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients
by: Huiping Huang, et al.
Published: (2022-07-01)

Busulfan administration replicated the characteristics of the epididymal initial segment observed in mice lacking testis-epididymis lumicrine signaling
by: Daiji KIYOZUMI
Published: (2024-02-01)

The use of platelet-rich plasma (PRP) to improve structural impairment of rat testis induced by busulfan
by: Farzaneh Dehghani, et al.
Published: (2019-05-01)

Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy
by: Valeria Guidolin, et al.
Published: (2023-03-01)

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
by: D'Urzo Anthony, et al.
Published: (2011-12-01)

Pharmacokinetics of rifampicin, isoniazid & pyrazinamide during daily & intermittent dosing: A preliminary study
by: Geetha Ramachandran, et al.
Published: (2023-01-01)

Once-daily use of inhaled corticosteroids: A new regimen in the treatment of persistent asthma
by: Jeffrey Leflein
Published: (2000-01-01)

Long-term efficacy and safety of once-daily nevirapine in combination with tenofovir and emtricitabine in the treatment of HIV-infected patients: a 72-week prospective multicenter study (TENOR-Trial)
by: Weberschock T, et al.
Published: (2009-12-01)